These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2261014)
21. Effect of zatebradine on contractility, relaxation and coronary blood flow. Breall JA; Watanabe J; Grossman W J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013 [TBL] [Abstract][Full Text] [Related]
22. Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones. Das J; Floyd DM; Kimball SD; Duff KJ; Vu TC; Lago MW; Moquin RV; Lee VG; Gougoutas JZ; Malley MF J Med Chem; 1992 Feb; 35(4):773-80. PubMed ID: 1542103 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127 [TBL] [Abstract][Full Text] [Related]
24. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function. Gout B; Jean J; Bril A J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent. Dämmgen J; Kadatz R; Diederen W Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712 [TBL] [Abstract][Full Text] [Related]
26. Alinidine as a model of the mode of action of specific bradycardic agents on SA node activity. van Ginneken AC; Bouman LN; Jongsma HJ; Duivenvoorden JJ; Opthof T; Giles WR Eur Heart J; 1987 Dec; 8 Suppl L():25-33. PubMed ID: 3451880 [TBL] [Abstract][Full Text] [Related]
27. Pharmacology of calcium antagonists. Schwartz A; Matlib MA; Balwierczak J; Lathrop DA Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055 [TBL] [Abstract][Full Text] [Related]
28. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
30. Biological activities of novel thienothiazine derivatives on heart and smooth muscle preparations of guinea pigs. Studenik C; Lemmens-Gruber R; Heistracher P Arzneimittelforschung; 1999 Sep; 49(9):740-4. PubMed ID: 10514900 [TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring. Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312 [TBL] [Abstract][Full Text] [Related]
32. Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration. Lillie C; Kobinger W Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):210-3. PubMed ID: 6527706 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents. Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S Bioorg Med Chem; 2004 Mar; 12(5):871-82. PubMed ID: 14980599 [TBL] [Abstract][Full Text] [Related]
34. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone. Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362 [TBL] [Abstract][Full Text] [Related]
35. [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles]. Raddino R; Poli E; Manca C; Ceconi C; Ferrari R Cardiologia; 1986 Jan; 31(1):47-53. PubMed ID: 3742515 [No Abstract] [Full Text] [Related]
36. 1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil. Kimball SD; Hunt JT; Barrish JC; Das J; Floyd DM; Lago MW; Lee VG; Spergel SH; Moreland S; Hedberg SA Bioorg Med Chem; 1993 Oct; 1(4):285-307. PubMed ID: 8081860 [TBL] [Abstract][Full Text] [Related]
37. Verapamil analogues with restricted molecular flexibility. Dei S; Romanelli MN; Scapecchi S; Teodori E; Chiarini A; Gualtieri F J Med Chem; 1991 Jul; 34(7):2219-25. PubMed ID: 2066995 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacological control of heart rate]. Sirtori CR; Franceschini G Ann Ital Med Int; 1994 Oct; 9 Suppl():29S-35S. PubMed ID: 7857754 [TBL] [Abstract][Full Text] [Related]
39. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart. Kobinger W; Lillie C Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions. Lillie C; Kobinger W Eur J Pharmacol; 1983 Jan; 87(1):25-33. PubMed ID: 6840187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]